홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Methyl chloroformate → (rac)-4-{3-[1-(5,7-Difluoro-quinolin-6-yl)-ethyl]-imidazo[1,2-b]pyridazin-6-yl}-piperazine-1-carboxylic acid methyl ester

HRID 1942072
인쇄

반응식

HRID 1942072 반응식
[F:1][C:2]1[C:11]([CH:12]([C:14]2[N:18]3[N:19]=[C:20]([N:23]4[CH2:28][CH2:27][NH:26][CH2:25][CH2:24]4)[CH:21]=[CH:22][C:17]3=[N:16][CH:15]=2)[CH3:13])=[C:10]([F:29])[CH:9]=[C:8]2[C:3]=1[CH:4]=[CH:5][CH:6]=[N:7]2.Cl[C:31]([O:33][CH3:34])=[O:32]>N1C=CC=CC=1>[CH3:34][O:33][C:31]([N:26]1[CH2:27][CH2:28][N:23]([C:20]2[CH:21]=[CH:22][C:17]3[N:18]([C:14]([CH:12]([C:11]4[C:2]([F:1])=[C:3]5[C:8](=[CH:9][C:10]=4[F:29])[N:7]=[CH:6][CH:5]=[CH:4]5)[CH3:13])=[CH:15][N:16]=3)[N:19]=2)[CH2:24][CH2:25]1)=[O:32]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 2

HCID 6586Methyl chloroformateHCID 50914336(rac)-5,7-Difluoro-6-[1-(6-piperazin-1-yl-imidazo[1,2-b]pyridazin-3-yl)-ethyl]-quinoline

생성물 1

HCID 50914493(rac)-4-{3-[1-(5,7-Difluoro-quinolin-6-yl)-ethyl]-imidazo[1,2-b]pyridazin-6-yl}-piperazine-1-carboxylic acid methyl ester

시약·촉매·용매 1

HCID 1049Pyridine용매

실험 절차

(rac)-5,7-Difluoro-6-[1-(6-piperazin-1-yl-imidazo[1,2-b]pyridazin-3-yl)-ethyl]-quinoline (Example 6, 35 mg, 0.089 mmol) was dissolved in pyridine (0.89 mL) and methyl chloroformate (0.010 mL, 0.133 mmol) was added. The RM was stirred at RT for 1.5 h. The mixture was concentrated and the residue was purified by flash chromatography and afforded the title compound as a beige foam (tR 3.70 min (conditions 1), MH+=453).

후처리

  1. concentrationThe mixture was concentrated
  2. customthe residue was purified by flash chromatography

출처 및 근거

ORD 기록
ord-8e4835ca268647eba4f876c7d60c147e
출처 데이터셋
uspto-grants-2013_03
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08389526B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트